{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T04:40:03Z","timestamp":1759034403258,"version":"3.44.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["1P1 HX002375-01\/SDR 16-348"],"award-info":[{"award-number":["1P1 HX002375-01\/SDR 16-348"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016939","name":"Myriad Genetics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016939","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006379","name":"Office of Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006379","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007217","name":"Health Services Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jad.2023.02.017","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T12:13:30Z","timestamp":1675685610000},"page":"368-377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Baseline platelet serotonin in a multi-site treatment study of depression in veterans administration patients: Distribution and effects of demographic variables and serotonin reuptake inhibitors"],"prefix":"10.1016","volume":"327","author":[{"given":"George M.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine M.","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin G.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Gelernter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Oslin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jad.2023.02.017_bb0005","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1086\/320112","article-title":"Broad and narrow heritabilities of quantitative traits in a founder population","volume":"68","author":"Abney","year":"2001","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.jad.2023.02.017_bb0010","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF02212938","article-title":"Elevated blood serotonin in autistic probands and their first-degree relatives","volume":"19","author":"Abramson","year":"1989","journal-title":"J. Autism Dev. Disord."},{"issue":"3","key":"10.1016\/j.jad.2023.02.017_bb0015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/13651501.2017.1411516","article-title":"Evaluation of peripheral serotonin content and \u03b12-adrenergic receptor function as potential markers for life-long recurrent depressive disorder by using methodological improvements","volume":"22","author":"Aleksovski","year":"2018","journal-title":"Int. J. Psychiatry Clin. Pract."},{"issue":"3","key":"10.1016\/j.jad.2023.02.017_bb0020","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.27673","article-title":"Evidence against a role of serotonin in liver regeneration in humans","volume":"62","author":"Alkozai","year":"2015","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jad.2023.02.017_bb0025","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1053\/cp.1999.v66.103402001","article-title":"Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine","volume":"66","author":"Alvarez","year":"1999","journal-title":"Clin. Pharmacol. Ther."},{"issue":"5\u20136","key":"10.1016\/j.jad.2023.02.017_bb0030","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ijdevneu.2004.06.006","article-title":"Peripheral and central neurochemical effects of the selective serotonin reuptake inhibitors (SSRIs) in humans and nonhuman primates: assessing bioeffect and mechanisms of action","volume":"22","author":"Anderson","year":"2004","journal-title":"Int. J. Dev. Neurosci."},{"year":"2022","author":"Anderson","series-title":"A systematic review of studies assessing the bioeffect of serotonin reuptake inhibitors at the serotonin transporter","key":"10.1016\/j.jad.2023.02.017_bb0035"},{"issue":"15","key":"10.1016\/j.jad.2023.02.017_bb0040","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/0024-3205(87)90696-5","article-title":"Steady-state model for plasma free and platelet serotonin in man","volume":"41","author":"Anderson","year":"1987","journal-title":"Life Sci."},{"issue":"11","key":"10.1016\/j.jad.2023.02.017_bb0045","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/0024-3205(87)90568-6","article-title":"Determination of serotonin in whole blood, platelet-rich plasma, platelet-poor plasma and plasma ultrafiltrate","volume":"40","author":"Anderson","year":"1987","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.jad.2023.02.017_bb0050","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00213-002-1034-1","article-title":"Serotonin in cisternal cerebrospinal fluid of rhesus monkeys: basal levels and effects of sertraline administration","volume":"161","author":"Anderson","year":"2002","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.jad.2023.02.017_bb0055","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1203\/01.PDR.0000136278.23672.A0","article-title":"Platelet serotonin in newborns and infants: ontogeny, heritability, and effect of in utero exposure to selective serotonin reuptake inhibitors","volume":"56","author":"Anderson","year":"2004","journal-title":"Pediatr. Res."},{"issue":"2\u20133","key":"10.1016\/j.jad.2023.02.017_bb0060","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00213-004-2011-7","article-title":"Time course of the effects of the serotonin-selective reuptake inhibitor sertraline on central and peripheral serotonin neurochemistry in the rhesus monkey","volume":"178","author":"Anderson","year":"2005","journal-title":"Psychopharmacology"},{"issue":"12","key":"10.1016\/j.jad.2023.02.017_bb0065","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.4088\/JCP.09r05786blu","article-title":"Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms","volume":"71","author":"Andrade","year":"2010","journal-title":"J. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2023.02.017_bb0070","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3324\/haematol.2014.106260","article-title":"Platelet count and aging","volume":"99","author":"Balduini","year":"2014","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.jad.2023.02.017_bb0075","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1600-0447.1978.tb06889.x","article-title":"5-Hydroxytryptamine content of the whole blood in psychiatric illness and alcoholism","volume":"57","author":"Banki","year":"1978","journal-title":"Acta Psychiatr. Scand."},{"issue":"1","key":"10.1016\/j.jad.2023.02.017_bb0080","doi-asserted-by":"crossref","first-page":"c10","DOI":"10.1159\/000075566","article-title":"Comorbid depression and platelet serotonin in hemodialysis patients","volume":"96","author":"Barisi\u0107","year":"2004","journal-title":"Nephron. Clin. Pract."},{"issue":"1\u20132","key":"10.1016\/j.jad.2023.02.017_bb0085","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jad.2011.08.013","article-title":"Decreased serotonin content and reduced agonist-induced aggregation in platelets of patients chronically medicated with SSRI drugs","volume":"136","author":"Bismuth-Evenzal","year":"2012","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.jad.2023.02.017_bb0090","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2125.1980.tb01057.x","article-title":"Long-term effect of lithium on the uptake of 5-hydroxytryptamine by human platelets","volume":"9","author":"Born","year":"1980","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.jad.2023.02.017_bb0095","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/acps.13235","article-title":"In search of a dose-response relationship in SSRIs-a systematic review, meta-analysis, and network meta-analysis","volume":"142","author":"Braun","year":"2020","journal-title":"Acta Psychiatr. Scand."},{"issue":"5","key":"10.1016\/j.jad.2023.02.017_bb0100","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/archpsyc.1993.01820170095015","article-title":"Seasonal effects on platelet 5-HT content in patients with OCD and controls","volume":"50","author":"Brewerton","year":"1993","journal-title":"Arch. Gen. Psychiatry"},{"issue":"605","key":"10.1016\/j.jad.2023.02.017_bb0105","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/pgmj.52.605.156","article-title":"5-Hydroxytryptamine (5-HT) in the whole-blood of patients with depressive illness","volume":"52","author":"Coppen","year":"1976","journal-title":"Postgrad. Med. J."},{"issue":"3","key":"10.1016\/j.jad.2023.02.017_bb0110","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/BF00464573","article-title":"Blood noradrenaline and 5-HT levels in depressed women during amitriptyline or lithium treatment","volume":"77","author":"Corona","year":"1982","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.jad.2023.02.017_bb0115","first-page":"137","article-title":"Diurnal and seasonal variations of melatonin and serotonin in women with seasonal affective disorder","volume":"53","author":"Danilenko","year":"1994","journal-title":"Arctic Med. Res."},{"issue":"5","key":"10.1016\/j.jad.2023.02.017_bb0120","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2165\/11589340-000000000-00000","article-title":"Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients","volume":"28","author":"de Abajo","year":"2011","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jad.2023.02.017_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110016","article-title":"Effect of vortioxetine vs. escitalopram on plasma BDNF and platelet serotonin in depressed patients","volume":"105","author":"Dvojkovic","year":"2021","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"16","key":"10.1016\/j.jad.2023.02.017_bb0130","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJM199704173361615","article-title":"Sertraline and breast-feeding","volume":"336","author":"Epperson","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.jad.2023.02.017_bb0135","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1176\/appi.ajp.158.10.1631","article-title":"Maternal sertraline treatment and serotonin transport in breast-feeding mother-infant pairs","volume":"158","author":"Epperson","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2023.02.017_bb0140","doi-asserted-by":"crossref","first-page":"e425","DOI":"10.1542\/peds.112.5.e425","article-title":"Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs","volume":"112","author":"Epperson","year":"2003","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.jad.2023.02.017_bb0145","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0024-3205(00)00620-2","article-title":"Serotonergic platelet variables in unmedicated patients suffering from major depression and healthy subjects: relationship between 5HT content and 5HT uptake","volume":"67","author":"Franke","year":"2000","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.jad.2023.02.017_bb0150","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1176\/appi.focus.18204","article-title":"Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis","volume":"18","author":"Furukawa","year":"2020","journal-title":"Focus"},{"issue":"6","key":"10.1016\/j.jad.2023.02.017_bb0155","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.euroneuro.2014.02.004","article-title":"Blood serotonin levels in autism spectrum disorder: a systematic review and meta-analysis","volume":"24","author":"Gabriele","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.jad.2023.02.017_bb0160","first-page":"19","article-title":"Risk of bleeding related to selective and non-selective serotonergic antidepressants: a case\/non-case approach using data from two pharmacovigilance databases","volume":"48","author":"Gahr","year":"2015","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jad.2023.02.017_bb0165","article-title":"Serotonin-affecting antidepressant use in relation to platelet reactivity","author":"Grech","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.jad.2023.02.017_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v028.i04","article-title":"FlexMix version 2: finite mixtures with concomitant variables and varying and constant parameters","volume":"28","author":"Gr\u00fcn","year":"2008","journal-title":"J. Stat. Softw."},{"issue":"4","key":"10.1016\/j.jad.2023.02.017_bb0175","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0049-3848(87)90218-0","article-title":"Reduced serotonin content and uptake in platelets from patients with essential hypertension: is a ouabain-like factor involved?","volume":"45","author":"Guicheney","year":"1987","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.jad.2023.02.017_bb0180","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2362.1988.tb01262.x","article-title":"Platelet serotonin content and plasma tryptophan in peri- and postmenopausal women: variations with plasma oestrogen levels and depressive symptoms","volume":"18","author":"Guicheney","year":"1988","journal-title":"Eur. J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.jad.2023.02.017_bb0185","doi-asserted-by":"crossref","first-page":"47","DOI":"10.31887\/DCNS.2007.9.1\/dhalperin","article-title":"Influence of antidepressants on hemostasis","volume":"9","author":"Halperin","year":"2007","journal-title":"Dialogues Clin. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.jad.2023.02.017_bb0190","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/09537109609079509","article-title":"Endogenous serotonin in human blood platelets: factors that may influence reference values","volume":"7","author":"Hervig","year":"1996","journal-title":"Platelets"},{"issue":"2","key":"10.1016\/j.jad.2023.02.017_bb0195","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0165-1781(96)02932-0","article-title":"Whole-blood serotonin in children and adolescents with mood and behavior disorders","volume":"65","author":"Hughes","year":"1996","journal-title":"Psychiatry Res."},{"issue":"6","key":"10.1016\/j.jad.2023.02.017_bb0200","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s11606-018-4776-0","article-title":"VA primary care and mental health providers\u2019 comfort with genetic testing: survey results from the PRIME care study","volume":"34","author":"Hull","year":"2019","journal-title":"J. Gen. Intern. Med."},{"issue":"4","key":"10.1016\/j.jad.2023.02.017_bb0205","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0006-3223(00)00956-2","article-title":"Reactivity of serotonin in whole blood: relationship with drug response in obsessive-compulsive disorder","volume":"49","author":"Humble","year":"2001","journal-title":"Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.jad.2023.02.017_bb0210","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/S0006-3223(96)00212-0","article-title":"Seasonal influence on platelet 5-HT levels in patients with recurrent major depression and schizophrenia","volume":"41","author":"Jakovljevi\u0107","year":"1997","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2023.02.017_bb0215","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1176\/appi.ajp.2015.15030331","article-title":"Systematic review and meta-analysis: dose-response relationship of selective serotonin reuptake inhibitors in major depressive disorder","volume":"173","author":"Jakubovski","year":"2016","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2023.02.017_bb0220","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0165-1781(00)00129-3","article-title":"Physiological characteristics of platelet\/circulatory serotonin: study on a large human population","volume":"94","author":"Jernej","year":"2000","journal-title":"Psychiatry Res."},{"issue":"2","key":"10.1016\/j.jad.2023.02.017_bb0225","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0165-1781(84)90056-8","article-title":"Reduced platelet serotonin in depression","volume":"13","author":"Le Quan-Bui","year":"1984","journal-title":"Psychiatry Res."},{"issue":"6","key":"10.1016\/j.jad.2023.02.017_bb0230","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1111\/j.1471-4159.1993.tb03522.x","article-title":"Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter","volume":"60","author":"Lesch","year":"1991","journal-title":"J. Neurochem."},{"issue":"2-3","key":"10.1016\/j.jad.2023.02.017_bb0235","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jphotobiol.2007.09.002","article-title":"The influence of daylight exposure on platelet 5-HT levels in patients with major depression and schizophrenia","volume":"89","author":"Ljubici\u0107","year":"2007","journal-title":"J. Photochem. Photobiol. B"},{"issue":"3","key":"10.1016\/j.jad.2023.02.017_bb0240","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0006-3223(92)90106-A","article-title":"Platelet and whole blood serotonin content in depressed inpatients: correlations with acute and life-time psychopathology","volume":"32","author":"Mann","year":"1992","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2023.02.017_bb0245","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0885-4505(87)90012-0","article-title":"Whole blood serotonin and plasma tryptophan using high-pressure liquid chromatography with electrochemical detection","volume":"37","author":"Marshall","year":"1987","journal-title":"Biochem. Med. Metab. Biol."},{"issue":"1","key":"10.1016\/j.jad.2023.02.017_bb0250","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1022234605695","article-title":"Low-dose fluvoxamine treatment of children and adolescents with pervasive developmental disorders: a prospective, open-label study","volume":"33","author":"Martin","year":"2003","journal-title":"J. Autism Dev. Disord."},{"issue":"7","key":"10.1016\/j.jad.2023.02.017_bb0255","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00004583-199807000-00017","article-title":"Effects of diagnosis, race, and puberty on platelet serotonin levels in autism and mental retardation","volume":"37","author":"McBride","year":"1998","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"year":"1988","author":"McLachlan","series-title":"Mixture Models: Inference And Applications to Clustering","key":"10.1016\/j.jad.2023.02.017_bb0260"},{"issue":"1","key":"10.1016\/j.jad.2023.02.017_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0049-3848(99)00015-8","article-title":"Platelet dense granules: structure, function and implications for haemostasis","volume":"95","author":"McNicol","year":"1999","journal-title":"Thromb. Res."},{"key":"10.1016\/j.jad.2023.02.017_bb0270","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1749-6632.1986.tb27906.x","article-title":"Platelet markers of suicidality","volume":"487","author":"Meltzer","year":"1986","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jad.2023.02.017_bb0275","article-title":"The serotonin theory of depression: a systematic umbrella review of the evidence","author":"Moncrieff","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"11","key":"10.1016\/j.jad.2023.02.017_bb0280","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jaac.2018.06.025","article-title":"Maternal serotonin levels are associated with cognitive ability and core symptoms in autism spectrum disorder","volume":"57","author":"Montgomery","year":"2018","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2023.02.017_bb0285","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0165-1781(91)90036-O","article-title":"Platelet serotonin in subtypes of schizophrenia and unipolar depression","volume":"38","author":"M\u00fcck-Seler","year":"1991","journal-title":"Psychiatry Res."},{"issue":"4","key":"10.1016\/j.jad.2023.02.017_bb0290","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00004583-200404000-00016","article-title":"Platelet serotonin levels in pervasive developmental disorders and mental retardation: diagnostic group differences, within-group distribution, and behavioral correlates","volume":"43","author":"Mulder","year":"2004","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2023.02.017_bb0295","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00004714-199802000-00011","article-title":"Serotonin transporter-blocking properties of nefazodone assessed by measurement of platelet serotonin","volume":"18","author":"Narayan","year":"1998","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2023.02.017_bb0300","article-title":"Study design and implementation of the Precision Medicine In Mental health Care (PRIME Care) Trial","volume":"101","author":"Oslin","year":"2020","journal-title":"Contemp. Clin. Trials"},{"issue":"2","key":"10.1016\/j.jad.2023.02.017_bb0305","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jama.2022.9805","article-title":"Effect of pharmacogenomic testing for drug-gene interactions on medication selection and remission of symptoms in major depressive disorder: the PRIME care randomized clinical trial","volume":"328","author":"Oslin","year":"2022","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jad.2023.02.017_bb0310","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF01247145","article-title":"The content and uptake of 5-HT by blood platelets in depressive patients","volume":"45","author":"Oxenkrug","year":"1979","journal-title":"J. Neural Transm."},{"issue":"7","key":"10.1016\/j.jad.2023.02.017_bb0315","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0006-3223(98)00020-1","article-title":"Peripheral serotonin measures in prepubertal psychiatric inpatients and normal children: associations with suicidal behavior and its risk factors","volume":"44","author":"Pfeffer","year":"1998","journal-title":"Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.jad.2023.02.017_bb0320","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1001\/archpsyc.1990.01810220042005","article-title":"Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results","volume":"47","author":"Pigott","year":"1990","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2023.02.017_bb0325","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/01.pra.0000410986.61593.46","article-title":"The use of biomarkers in psychiatric research: how serotonin transporter occupancy explains the dose-response curves of SSRIs","volume":"18","author":"Preskorn","year":"2012","journal-title":"J. Psychiatr. Pract."},{"issue":"2","key":"10.1016\/j.jad.2023.02.017_bb0330","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0327(92)90019-3","article-title":"Platelet serotonin and plasma tryptophan decreases in endogenous depression. Clinical, therapeutic, and biological correlations","volume":"24","author":"Quintana","year":"1992","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2023.02.017_bb0335","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jad.2021.01.034","article-title":"PRIME Care Executive Committee, Oslin DW. Prevalence of predicted gene-drug interactions for antidepressants in the treatment of major depressive disorder in the Precision Medicine in Mental Health Care Study","volume":"282","author":"Ramsey","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2023.02.017_bb0340","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jad.2021.12.116","article-title":"Daily steps and depressive symptoms: a longitudinal evaluation of patients with major depressive disorder in the precision medicine in mental health care study","volume":"300","author":"Ramsey","year":"2022","journal-title":"J. Affect. Disord."},{"issue":"215","key":"10.1016\/j.jad.2023.02.017_bb0345","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0076-6879(92)15065-K","article-title":"Platelet serotonin transporter","volume":"1992","author":"Rudnick","year":"1992","journal-title":"Methods Enzymol."},{"issue":"3","key":"10.1016\/j.jad.2023.02.017_bb0350","first-page":"271","article-title":"The level and diurnal rhythm of serum serotonin in manic-depressive patients","volume":"22","author":"Sarai","year":"1968","journal-title":"Folia Psychiatr. Neurol. Jpn."},{"issue":"12","key":"10.1016\/j.jad.2023.02.017_bb0355","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/0006-3223(87)90100-4","article-title":"Decreased plasma serotonin in melancholic patients: a study with clomipramine","volume":"22","author":"Sarrias","year":"1987","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2023.02.017_bb0360","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.annepidem.2005.06.052","article-title":"Platelet counts differ by sex, ethnicity, and age in the United States","volume":"16","author":"Segal","year":"2006","journal-title":"Ann. Epidemiol."},{"issue":"1-3","key":"10.1016\/j.jad.2023.02.017_bb0365","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0165-0327(98)00060-3","article-title":"Platelet 5-HT and plasma MHPG levels in patients with bipolar I and bipolar II depressions and normal controls","volume":"52","author":"Shiah","year":"1999","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2023.02.017_bb0375","doi-asserted-by":"crossref","DOI":"10.1177\/20451253211067656","article-title":"Clinical practice guideline recommendations on tapering and discontinuing antidepressants for depression: a systematic review","volume":"12","author":"S\u00f8rensen","year":"2022","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.jad.2023.02.017_bb0370","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41380-021-01285-w","article-title":"The relationship between dose and serotonin transporter occupancy of antidepressants-a systematic review","volume":"27","author":"S\u00f8rensen","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2023.02.017_bb0380","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1176\/ajp.140.1.26","article-title":"Hyperserotonemia and platelet serotonin uptake and release in schizophrenia and affective disorders","volume":"140","author":"Stahl","year":"1983","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2023.02.017_bb0385","first-page":"476","article-title":"Reduction of blood platelet serotonin levels in manic and depressed patients","volume":"30","author":"Takahashi","year":"1976","journal-title":"Folia Psychiatr. Neurol. Jpn."},{"key":"10.1016\/j.jad.2023.02.017_bb0390","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1192\/bjp.106.444.884","article-title":"Blood platelet 5-hydroxytryptamine levels in psychiatric patients","volume":"106","author":"Todrick","year":"1960","journal-title":"J. Ment. Sci."},{"issue":"1","key":"10.1016\/j.jad.2023.02.017_bb0395","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1186\/s12888-020-02919-z","article-title":"Primary care and mental health providers' perceptions of implementation of pharmacogenetics testing for depression prescribing","volume":"20","author":"Vest","year":"2021","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2023.02.017_bb0400","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF01262729","article-title":"Increased platelet serotonin in bipolar depression and hypomania","volume":"42","author":"Wirz-Justice","year":"1978","journal-title":"J. Neural Transm."},{"issue":"1","key":"10.1016\/j.jad.2023.02.017_bb0405","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF01262728","article-title":"Seasonal incidence of an altered diurnal rhythm of platelet serotonin in unipolar depression","volume":"42","author":"Wirz-Justice","year":"1978","journal-title":"J. Neural Transm."},{"issue":"1","key":"10.1016\/j.jad.2023.02.017_bb0410","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF01252961","article-title":"Diurnal and seasonal variations in human platelet serotonin in man","volume":"41","author":"Wirz-Justice","year":"1977","journal-title":"J. Neural Transm."},{"issue":"2","key":"10.1016\/j.jad.2023.02.017_bb0415","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/PSY.0000000000000145","article-title":"Cortisol, platelet serotonin content, and platelet activity in patients with major depression and type 2 diabetes: an exploratory investigation","volume":"77","author":"Zahn","year":"2015","journal-title":"Psychosom. Med."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032723001702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032723001702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T03:59:02Z","timestamp":1759031942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032723001702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":83,"alternative-id":["S0165032723001702"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2023.02.017","relation":{},"ISSN":["0165-0327"],"issn-type":[{"type":"print","value":"0165-0327"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Baseline platelet serotonin in a multi-site treatment study of depression in veterans administration patients: Distribution and effects of demographic variables and serotonin reuptake inhibitors","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2023.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}